Content deleted Content added
JCW-CleanerBot (talk | contribs) |
Changed Category:Amino acids to Category:Alpha-Amino acids |
||
(7 intermediate revisions by 4 users not shown) | |||
Line 5: | Line 5: | ||
| ImageFile=Allylglycine.png |
| ImageFile=Allylglycine.png |
||
| ImageSize=180px |
| ImageSize=180px |
||
| |
| PIN = 2-Aminopent-4-enoic acid |
||
| OtherNames= |
| OtherNames= |
||
|Section1={{Chembox Identifiers |
|Section1={{Chembox Identifiers |
||
Line 33: | Line 33: | ||
|Section3={{Chembox Hazards |
|Section3={{Chembox Hazards |
||
| MainHazards=[[Convulsant]] |
| MainHazards=[[Convulsant]] |
||
| LD50=147-195 mg/kg (mice)<ref>{{cite journal |
| LD50=147-195 mg/kg (mice, intraperitoneal)<ref>{{cite journal|journal=Clinical and Experimental Pharmacology and Physiology|volume=4|issue=3|pages=263–6|doi=10.1111/j.1440-1681.1977.tb02623.x|pmid=891041|year=1977|last1=Piepho|first1=R. W|title=Chronopharmacology of Strychnine and Allylglycine in the Mouse|last2=Friedman|first2=A. H|s2cid=25088608}}</ref> |
||
| FlashPt= |
| FlashPt= |
||
| AutoignitionPt = |
| AutoignitionPt = |
||
Line 39: | Line 39: | ||
}} |
}} |
||
'''Allylglycine''' is a [[glycine]] derivative. It is an [[Enzyme inhibitor|inhibitor]] of [[glutamate decarboxylase]].<ref name="pmid3205383">{{cite journal |vauthors =Abshire VM, Hankins KD, Roehr KE, DiMicco JA |title=Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate |journal=Neuropharmacology |volume=27 |issue=11 |pages=1171–7 |date=November 1988 |pmid=3205383 |doi= 10.1016/0028-3908(88)90013-5| |
'''Allylglycine''' is a [[glycine]] derivative. It is an [[Enzyme inhibitor|inhibitor]] of [[glutamate decarboxylase]].<ref name="pmid3205383">{{cite journal |vauthors =Abshire VM, Hankins KD, Roehr KE, DiMicco JA |title=Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate |journal=Neuropharmacology |volume=27 |issue=11 |pages=1171–7 |date=November 1988 |pmid=3205383 |doi= 10.1016/0028-3908(88)90013-5|s2cid=32655173 }}</ref> Inhibition of glutamate decarboxylase blocks [[GABA]] [[biosynthesis]], leading to lower levels of the [[neurotransmitter]].<ref name="pmid18308797">{{cite journal |vauthors =Sajdyk T, Johnson P, Fitz S, Shekhar A |title=Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior |journal=J. Psychopharmacol. (Oxford) |volume=22 |issue=6 |pages=633–41 |date=August 2008 |pmid=18308797 |doi=10.1177/0269881107082902 |pmc=3065212}}</ref> Allylglycine is known to induce [[seizure]]s in animals studies, presumably due to this GDC-inhibiting activity.<ref name="pmid1654571">{{cite journal |vauthors =Thomas J, Yang YC |title=Allylglycine induced seizures in male and female rats |journal=Physiol. Behav. |volume=49 |issue=6 |pages=1181–3 |date=June 1991 |pmid=1654571|doi=10.1016/0031-9384(91)90348-R |s2cid=10506822 }}</ref> |
||
==See also== |
|||
*[[3-Mercaptopropionic acid]] |
|||
==References== |
==References== |
||
Line 48: | Line 51: | ||
{{Convulsants}} |
{{Convulsants}} |
||
[[Category:Amino acids]] |
[[Category:Alpha-Amino acids]] |
||
[[Category:Convulsants]] |
[[Category:Convulsants]] |
||
[[Category:Glutamate decarboxylase inhibitors]] |
[[Category:Glutamate decarboxylase inhibitors]] |
Latest revision as of 15:46, 17 September 2023
Names | |
---|---|
Preferred IUPAC name
2-Aminopent-4-enoic acid | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.028.809 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C5H9NO2 | |
Molar mass | 115.13 g/mol |
Appearance | white crystalline powder |
Density | 1.098 g/mL |
Melting point | 265 °C (509 °F; 538 K) |
Boiling point | 231 °C (448 °F; 504 K) |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Convulsant |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
147-195 mg/kg (mice, intraperitoneal)[1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Allylglycine is a glycine derivative. It is an inhibitor of glutamate decarboxylase.[2] Inhibition of glutamate decarboxylase blocks GABA biosynthesis, leading to lower levels of the neurotransmitter.[3] Allylglycine is known to induce seizures in animals studies, presumably due to this GDC-inhibiting activity.[4]
See also[edit]
References[edit]
- ^ Piepho, R. W; Friedman, A. H (1977). "Chronopharmacology of Strychnine and Allylglycine in the Mouse". Clinical and Experimental Pharmacology and Physiology. 4 (3): 263–6. doi:10.1111/j.1440-1681.1977.tb02623.x. PMID 891041. S2CID 25088608.
- ^ Abshire VM, Hankins KD, Roehr KE, DiMicco JA (November 1988). "Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate". Neuropharmacology. 27 (11): 1171–7. doi:10.1016/0028-3908(88)90013-5. PMID 3205383. S2CID 32655173.
- ^ Sajdyk T, Johnson P, Fitz S, Shekhar A (August 2008). "Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior". J. Psychopharmacol. (Oxford). 22 (6): 633–41. doi:10.1177/0269881107082902. PMC 3065212. PMID 18308797.
- ^ Thomas J, Yang YC (June 1991). "Allylglycine induced seizures in male and female rats". Physiol. Behav. 49 (6): 1181–3. doi:10.1016/0031-9384(91)90348-R. PMID 1654571. S2CID 10506822.